BNP-7787 is primarily investigated for its potential use in reducing the side effects associated with chemotherapy, particularly those caused by cisplatin. It is explored as a chemoprotective agent that may help mitigate nephrotoxicity and neurotoxicity, which are common adverse effects of cisplatin treatment. By acting as a thiol-based compound, it is believed to protect normal cells from damage while allowing the chemotherapy to target cancer cells effectively. Its application is focused on improving patient tolerance to chemotherapy and enhancing the overall safety profile of cancer treatment regimens.